SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-004625
Filing Date
2019-01-08
Accepted
2019-01-08 16:15:36
Documents
5
Period of Report
2019-01-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d680226d8k.htm 8-K 18154
2 EX-99.1 d680226dex991.htm EX-99.1 5021
3 GRAPHIC g680226ex99_1p1g1.jpg GRAPHIC 156948
4 GRAPHIC g680226ex99_1p29g1.jpg GRAPHIC 236142
5 GRAPHIC g680226ex99_1p2g1.jpg GRAPHIC 190598
  Complete submission text file 0001193125-19-004625.txt   828594
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26727 | Film No.: 19516124
SIC: 2834 Pharmaceutical Preparations